Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 4Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 8Osteosarcoma 3Vomiting 2Neuroectodermal Tumors, Primitive, Peripheral 2Nausea 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Sarcoma, Synovial 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Liposarcoma 1Leukemia 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hepatoblastoma 1Fibrosarcoma 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Chemotherapeutic Agent Toxicity 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

pegfilgrastim 1X-Rays 1Radiotherapy, Conformal 1Ifosfamide 1Glutamine 1Fluorodeoxyglucose F18 1Doxorubicin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Fibrosarcoma × Ifosfamide × Clear all
NCT00346125 2022-12-15

PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
70 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡